You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 9,216,174


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,216,174 protect, and when does it expire?

Patent 9,216,174 protects XIIDRA and is included in one NDA.

This patent has twenty-two patent family members in fourteen countries.

Summary for Patent: 9,216,174
Title:Modulators of cellular adhesion
Abstract: The present invention provides compounds having formula (I): ##STR00001## and pharmaceutically acceptable derivatives thereof, wherein R.sub.1-R.sub.4, n, p, A, B, D, E, L and AR.sup.1 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1).
Inventor(s): Shen; Wang (San Mateo, CA), Barr; Kenneth (Boston, MA), Oslob; Johan D. (Sunnyvale, CA), Zhong; Min (Foster City, CA)
Assignee: SARCODE BIOSCIENCE INC. (Brisbane, CA)
Application Number:13/969,968
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,216,174
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,216,174

Introduction

United States Patent 9,216,174, titled "Modulators of cellular adhesion," is a patent that deals with compounds and methods for modulating cellular adhesion. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Details

  • Publication Number: US9216174B2
  • Publication Date: This patent was published on December 15, 2015, although the application was filed on September 1, 2011, as a continuation of earlier applications[5].

Inventors and Assignees

The patent lists the inventors and the assignees, which are crucial for understanding the ownership and the potential for licensing or litigation.

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broad scope of the invention, while dependent claims narrow down the scope by adding specific limitations.

  • Independent Claims: These claims outline the core invention, such as the compounds, their structures, and their use in modulating cellular adhesion.
  • Dependent Claims: These claims build upon the independent claims by specifying particular aspects, such as specific chemical moieties, dosages, or methods of administration.

Claim Scope

The claims in this patent are detailed and specific, covering various aspects of the modulators of cellular adhesion:

  • Chemical Compounds: The patent claims specific chemical compounds and their derivatives that act as modulators of cellular adhesion.
  • Methods of Use: Claims include methods for using these compounds in therapeutic applications, such as treating diseases related to cellular adhesion.
  • Pharmaceutical Compositions: The patent also claims pharmaceutical compositions containing these compounds and their use in various formulations[5].

Prior Art and Citation Analysis

Prior Art Keywords

The prior art keywords listed in the patent provide insight into the existing knowledge in the field at the time of the application. These include terms like "compound," "mmol," "aryl," "heteroaryl," and "moiety," indicating the chemical nature of the invention[5].

Citation Data

Using tools like the Common Citation Document (CCD) provided by the USPTO, one can consolidate the prior art cited by all participating offices for the family members of this patent application. This helps in understanding the global patent landscape and how this invention fits into it[1].

Patent Landscape

Global Patent Family

The patent is part of a global patent family, with applications filed in multiple jurisdictions. Tools like the Global Dossier service provided by the USPTO allow users to see the patent family for a specific application, including all related applications filed at participating IP Offices[1].

Competitor Analysis

Analyzing the patent landscape involves identifying competitors who may be working on similar inventions. This can be done by searching international patent offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Legal Status and Litigation

Current Status

The legal status of the patent indicates whether it is active, expired, or under litigation. As of the current date, the status would need to be verified through official sources like the USPTO or Google Patents, which may indicate if the patent has expired or is still in force[5].

Litigation History

Checking for any litigation history involving this patent can provide insights into its validity and enforceability. For example, if the patent has been involved in infringement cases, this could impact its current status and future applications[2].

Economic and Market Impact

Market Relevance

The economic impact of this patent can be significant if the compounds and methods described are commercially viable and address a substantial market need. The therapeutic applications of modulators of cellular adhesion could be in high demand, especially in fields like oncology or immunology.

Licensing and Collaboration

The patent's value can also be leveraged through licensing agreements or collaborations with other companies. This can expand the reach of the invention and generate revenue for the patent holders.

Research and Development

Data and Statistics

Using datasets like the Patent Claims Research Dataset provided by the USPTO, researchers can analyze trends in patent claims and scope. This can help in understanding the broader research landscape and how this patent fits into it[3].

Future Directions

The research and development in the field of cellular adhesion modulators is ongoing. Analyzing this patent in the context of current research can help identify future directions and potential areas for innovation.

Conclusion

Key Takeaways

  • Patent Scope: The patent covers specific chemical compounds and methods for modulating cellular adhesion.
  • Claims Analysis: Independent and dependent claims define the invention's scope, including chemical structures and therapeutic applications.
  • Prior Art: The patent's prior art keywords and citation data provide context within the existing knowledge in the field.
  • Global Patent Family: The patent is part of a global family with applications in multiple jurisdictions.
  • Legal Status: The current legal status and any litigation history are crucial for understanding the patent's enforceability.
  • Market Impact: The patent's economic impact depends on its commercial viability and market demand.

FAQs

  1. What is the main subject of United States Patent 9,216,174?

    • The main subject is modulators of cellular adhesion, specifically chemical compounds and methods for their use.
  2. How can I search for similar patents globally?

    • You can use tools like the Global Dossier service and searchable databases from international intellectual property offices such as the EPO, JPO, and WIPO[1].
  3. What is the significance of prior art in patent analysis?

    • Prior art helps in understanding the existing knowledge in the field at the time of the patent application and how the invention differs from or builds upon this knowledge.
  4. How can I determine the current legal status of a patent?

    • You can check the legal status through official sources like the USPTO or Google Patents, which provide up-to-date information on patent status[5].
  5. What are the potential economic impacts of this patent?

    • The patent could have significant economic impacts if the described compounds and methods are commercially viable and address substantial market needs, particularly in therapeutic applications.

Sources

  1. USPTO - Search for patents
  2. US District Court Document - Novartis Pharmaceuticals Corporation vs. Sun Pharmaceuticals Industries Ltd.
  3. USPTO - Patent Claims Research Dataset
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office
  5. Google Patents - US9216174B2 - Modulators of cellular adhesion

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,216,174

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch And Lomb Inc XIIDRA lifitegrast SOLUTION/DROPS;OPHTHALMIC 208073-001 Jul 11, 2016 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.